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Abstract
Background: Fear of childbirth may reduce the womens’ pain tolerance during labour and may have impact on
the mother-infant interaction. We aimed to assess (1) the association between fear of childbirth antepartum and
subsequent request for pharmacological pain relief, and (2) the association between the used method of pain relief
and experienced fear of childbirth as reported postpartum in low risk labouring women.
Methods: Secondary analysis of the RAVEL study, a randomised controlled trial comparing remifentanil patient
controlled analgesia (PCA) and epidural analgesia to relieve labour pain. The RAVEL study included 409 pregnant
women at low risk for obstetric complications at 18 midwifery practices and six hospitals in The Netherlands (NTR
3687). We measured fear of childbirth antepartum and experienced fear of childbirth reported postpartum, using
the Wijma Delivery Expectancy/Experience Questionnaire.
Results: Women with fear of childbirth antepartum more frequently requested pain relief compared to women
without fear of childbirth antepartum, but this association did not reach statistical significance (adjusted odds ratio
(aOR2.0; 95% confidence interval (CI) 0.8–4.6). Women who received epidural analgesia more frequently reported
fear of childbirth postpartum compared to women who did not receive epidural analgesia (aOR3.5; CI 1.5–8.2),
while the association between remifentanil-PCA and fear of childbirth postpartum was not statistically significant
(aOR1.7; CI 0.7–4.3).
Conclusions: Women with fear of childbirth antepartum more frequently requested pain relief compared to
women without fear of childbirth antepartum, but this association was not statistically significant. Women who
received pharmacological pain relief more frequently reported that they had experienced fear of childbirth during
labour compared to women who did not receive pain relief. Based on our data epidural analgesia with continuous
infusion does not seem to be preferable over remifentanil-PCA as method of pain relief when considering fear of
childbirth postpartum.
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Background
Labour pain is considered as severe pain [1]. Womens’ ex-
periences of labour pain vary and are influenced by the
physiological and psychological processes of birth and the
extent to which women perceive pain [2]. Fear of child-
birth, meaning pregnancy and childbirth related fear and
anxiety, can lead to an increased pain perception [3, 4].
Due to its possible impact on both the mother and on the
mother-infant interaction fear of childbirth has gained
growing attention [4–6]. One can distinguish fear of child-
birth antepartum –measured during pregnancy– from fear
of childbirth postpartum, which is fear experienced during
labour and measured after giving birth [7].
Previous studies have shown that women with fear of
childbirth had reduced pain tolerance [4, 8]. Adams et al.
found that women with fear of childbirth more often re-
quested epidural analgesia during labour than women
without fear of childbirth (45% vs 27%, p < 0.001) [9].
Saisto et al. found that 15% of the women with fear of
childbirth postpartum, mentioned experienced frightening
pain as principal cause of fear [10].
Pharmacological methods of pain relief are widely used
during labour [2]. There is variation in the methods of
pain relief and in the percentage of women using pain
relief [2, 11–13]. Pharmacological pain relief reduces the
pain experienced during labour [2, 14, 15]. However,
childbirth satisfaction is not only influenced by pain and
pain relief but also by other factors such as the attitude
of the caregivers and involvement of the woman in deci-
sion making during labour [16]. There is a lack of robust
data assessing the experiences of women who receive
and who do not receive analgesia and their childbirth ex-
perience or well-being, including fear of childbirth.
In The Netherlands women at low risk for obstetric
complications start labour in primary midwife-led care. In
case of a request for pharmacological pain relief –with the
exception of Entonox- women will be referred to
hospital-based obstetric-led care and the primary care
midwife is no longer involved in providing care. A referral
during labour -for pharmacological pain relief or other
medical reasons- could be influenced by fear of childbirth
antepartum or could influence experienced fear of child-
birth reported by women postpartum [5, 8–10, 17].
Both the relation between fear of childbirth antepar-
tum and request for pain relief as well as administering
pharmacological pain relief and experienced fear of
childbirth reported postpartum, have rarely been studied
in a low risk population. More knowledge about this
topic could be used for counselling women for decisions
regarding the use of pharmacological pain relief, the type
of pain relief and the preferred place of birth.
The aim of our study was to assess, in low risk labour-
ing women, the association between fear of childbirth
antepartum and request for pharmacological pain relief
(1). Furthermore, we assessed the association between
the used method of pain relief and experienced fear of
childbirth as reported postpartum (2).
Methods
Design
We studied the association between on the one hand fear
of childbirth antepartum and a request for pharmaco-
logical pain relief (either remifentanil patient controlled
analgesia (PCA) or epidural analgesia), and on the other
hand the association between the method of pharmaco-
logical pain relief and fear of childbirth -experienced dur-
ing labour- reported postpartum in women who
participated in the RAVEL trial (NTR3687). This was a
randomised equivalence trial among 409 low risk pregnant
women comparing two pharmacological pain relief
methods – remifentanil-PCA and epidural analgesia– in
case of a request for pain relief during labour [14]. In this
trial satisfaction with pain relief and pain scores were
compared over the total duration of labour among low
risk women randomised for remifentanil-PCA or epidural
analgesia. Maternal satisfaction with labour pain scores
and pain intensity scores were assessed hourly from the
start of active labour until the second stage of labour in all
participating women. Women receiving remifentanil-PCA
were less satisfied with their pain relief than women using
epidural analgesia [14].
The RAVEL study was approved by the ethics commit-
tee of the University Medical Centre Leiden and the
boards of the six participating hospitals: Onze Lieve
Vrouwen Gasthuis Amsterdam, VU Medical Centre
Amsterdam, Academic Medical Centre Amsterdam, Lu-
cas Andreas Hospital Amsterdam, St. Antonius hospital
Nieuwegein, Diakonessen hospital Utrecht (ref. no.
P10.240; 26 July 2012). Written informed consent was
obtained of all participants and women younger than
18 years were not eligible.
The participants filled out the Wijma Delivery Expect-
ancy/Experience Questionnaire ante-partum version
(W-DEQ A) and gave their informed consent for the re-
searchers to extract data from the maternity care record.
These data were obtained by the participant’s primary care
midwife. Six weeks postpartum participants received a re-
minder e-mail from the researchers to complete the
W-DEQ post-partum version (W-DEQ B). Completed
questionnaires were sent to the researchers by post.
Definition and measurements of the outcome
Women were asked to complete the W-DEQ A during
the third trimester of pregnancy and the W-DEQ B at
six weeks postpartum, consistent with other studies. The
W-DEQ A was developed to measure women’s feelings
and fear before labour by means of the woman’s cogni-
tive appraisal regarding the labour process. Similarly, the
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W-DEQ B was developed to measure, in retrospect, feel-
ings and fear that women had experienced during child-
birth. W-DEQ is a self-assessment scale -containing 33
items in both questionnaires- regarding childbirth (ques-
tions like, ‘How do you think you will feel in general dur-
ing labour and delivery?’ in W-DEQ A or ‘How did you
feel in general during labour and delivery?’ in W-DEQ B:
extremely weak/not at all weak; extreme panic/not at all
panicked; extreme trust/no trust at all). Answers are
given on a six-point Likert scale ranging from ‘not at all’
(0) to ‘extremely’ (5), yielding a minimum score of 0 and
a maximum score of 165, with higher scores reflecting a
greater degree of fear of childbirth. According to the lit-
erature we classified the W-DEQ score in three categor-
ies [7, 9, 18, 19]. A score < 85 presenting women with
low to moderate fear of childbirth; a score between 85
and less than 100 indicating women with an intense fear
of childbirth, influencing the woman’s well-being, and
women with a score of 100 or higher were defined as hav-
ing a very intense, fobic fear. The internal consistency for
both versions of the W-DEQ is shown to be good (Cron-
bach’s alpha = 0.93) [7].
Definition and measurements of potentially confounding
variables
We selected potentially confounding variables associated
with fear of childbirth on the basis of the literature and
one variable (obstetric complication) was added from clin-
ical experience. Pre-existing psychological conditions –
mainly anxiety and depression – could have an impact on
the expectations of labour and could confound the rela-
tion between fear of childbirth and request for pain relief
[7, 18–21]. To identify pre-existing psychological condi-
tions, we measured anxiety and depression by using the
Hospital Anxiety Depression Scale (HADS). Women were
asked to complete the HADS questionnaire simultan-
eously with the W-DEQ questionnaire at both time points.
The HADS is a questionnaire containing a 7-item anxiety
scale and a 7-item depression scale, both of which have
scores ranging from 0 to 21. The HADS is designed to
measure depression and anxiety disorders among patients
in a non-psychiatric clinic and is considered to be a reli-
able and efficient questionnaire [22–24]. A cut off score of
≥11 points on each scale was used to define the existence
of anxiety and/or depression [24].
Other potentially confounding variables for either
fear of childbirth antepartum and/or postpartum were
young maternal age [18], low education level [18],
previous first trimester loss [24], parity [5, 9, 17, 24],
(previous) emergency caesarean section or operative
vaginal delivery [5, 9, 10, 17], use of epidural analgesia
during labour [9, 10], duration of labour (defined as the
time from start active labour to birth) [9, 10], induction/
augmentation of labour [8, 10, 17].
Partly from the literature, combined with clinical
experience, we added obstetric complication as a poten-
tial confounder. In the RAVEL trial obstetric complica-
tions were defined as post spinal headache, postpartum
haemorrhage (≥1000 ml in the 24 h after delivery or ad-
ministration of blood products), uterine rupture, eclamp-
sia, amniotic fluid embolism, myocardial infarction or
admission to ICU) and/or neonatal admission to intensive
care [10]. Due to, firstly the small study population and
secondly, the low risk population in which we expected
low rates of obstetric complications and interventions, we
decided to combine these into one variable ‘obstetric
intervention/complication’, with interventions including
induction/augmentation of labour, assisted vaginal
delivery, emergency caesarean section and obstetric
complications into one variable. Additional file 1 shows
the frequencies of these variables. As our study population
consisted of women with a low obstetrical risk, women
with a previous caesarean were excluded. For the second
research question we added fear of childbirth antepartum
as a potential confounder [17, 20].
Analysis
To determine whether women who completed the W-DEQ
questionnaires were representative for the total study popu-
lation, we compared the baseline characteristics of women
who completed the antepartum W-DEQ questionnaires
with those of women who did not. The same was done for
the postpartum W-DEQ questionnaires. To do so, we used
the chi-square test, Mann-Whitney U test and the Student’s
t-test. Prior to the analysis, the W-DEQ and HADS scores
were examined for missing items. For the W-DEQ a max-
imum of two missing items was allowed, and missing items
were assigned the mean score of all other items for that
specific participant’s scale.
Multiple logistic regression analysis was used to deter-
mine whether there was an association between fear of
childbirth antepartum and a request for pain relief (re-
search question 1). All potentially confounding factors
were included in the multiple logistic regression analysis,
with a request for pain relief as the dependent variable.
To study whether the method of pain relief,
remifentanil-PCA or epidural analgesia (randomly allo-
cated), was associated with fear of childbirth reported
postpartum we used multiple logistic regression analyses
(research question 2). Because of the relatively small
group of women with fear of childbirth reported post-
partum we had to determine the most relevant potential
confounders for the multiple regression analysis. We did
a pre-selection with univariable logistic regression ana-
lysis. Variables with a p-value ≤ 0.2 were included in a
stepwise multivariable logistic regression analysis using a
backward selection method to determine factors most
strongly associated with fear of childbirth reported
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postpartum [25]. All tests of significance were two-sided,
with a p value ≤ 0.05 indicating statistical significance.
Data were analyzed using SPSS (version 24; SPSS Inc.,
Chicago, IL).
Results
Of the 409 women participating in the RAVEL trial, 374
(91%) women completed the W-DEQ questionnaire ante-
partum and 315 (77%) completed the W-DEQ question-
naire postpartum. Figure 1a&b shows the flow charts for
both measures. The baseline characteristics of women
who completed the W-DEQ questionnaire antepartum
and women who did not were comparable. Of women
who completed the W-DEQ questionnaires postpartum
and women who did not, the baseline characteristics were
comparable, except for the variables random allocation,
ethnic origin and education level. More women rando-
mised for remifentanil-PCA, more Western women and
more women with a higher education level completed the
W-DEQ questionnaires postpartum (p = 0.003, p = 0.008
and p = 0.004 respectively). Of the 53 women with a low
education level 12 (23%) experienced (very) intense fear of
childbirth postpartum compared to 24 (9%) of the 253
women with a high education level. Table 1 shows the
baseline characteristics of all the women who participated
in the RAVEL study and of the women who completed
the W-DEQ A and the W-DEQ B.
Association between fear of childbirth antepartum and
request for pain relief
The mean W-DEQ sum score antepartum was 63 (SD
16). Thirty women (30/374, 8%) had an intense fear of
childbirth, while two women (< 1%) had very intense fear
of childbirth. As only two women had a score of 100 or
higher, we decided to combine the women with intense
and very intense fear of childbirth in one group. Of the
374 women, 188 (50%) requested pain relief (Fig. 1a). No
differences were found between the characteristics of
women who requested pharmacological pain relief and
women who did not, except for the variable parity. The
group of women with a request for pain relief consist of
more nulliparous women compared to group without a
request for pain relief (< 0.001)(Additional file 2). We
did find an adjusted odds ratio of 2.0 (CI 0.8–4.6) be-
tween fear of childbirth antepartum and request for pain
relief after adjusting for parity, maternal age, education
level, previous first trimester loss, antepartum HADS
score and previous vaginal instrumental delivery but this
association was not statistically significant (Table 2).
Association between method of pain relief and fear of
childbirth reported postpartum
The mean W-DEQ sum score postpartum was 55 (SD
24), 26 of the 315 (8%) women had experienced intense
fear of childbirth and 11 (4%) women had experienced
very intense fear of childbirth. We decided to combine
women with intense and very intense fear of childbirth
for the analysis. Of the 315 women, 130 (41%) women
received pain relief: 72 (23%) women received
remifentanil-PCA, 55 (18%) women received epidural
analgesia, 3 (1%) women received another opioid and
185 (59%) women did not receive pain relief (Fig. 1b). Of
the women who requested pain relief, 28/158 (18%)
women did not receive pain relief although requested,
mostly due to delivery before analgesia was in place.
In the univariable logistic regression analyses we found
the administration of pharmacological pain relief to be as-
sociated with fear of childbirth reported postpartum com-
pared to deliveries without pharmacological pain relief (p
= 0.002). Women who received epidural analgesia, more
often reported fear of childbirth postpartum compared to
women who did not use pain relief (OR 4.2; CI 1.9–9.6),
while the association with remifentanil-PCA was not sta-
tistically significant (OR 1.8; CI 0.7–4.3). In the univariable
analysis we selected the variables fear of childbirth ante-
partum, parity, education level, duration of labour and ob-
stetric intervention/complication as they met the criterion
p < 0.2. A higher level of fear of childbirth antepartum was
related to a higher level of fear of childbirth reported post-
partum. Nulliparity predicted a higher chance for fear of
childbirth reported postpartum than multiparity. A higher
education level and a longer duration of labour were pre-
dictive for fear of childbirth reported postpartum. Also,
the occurrence of an obstetric intervention/complication
was predictive for fear of childbirth reported postpartum
(Additional file 3).
After multivariable logistic regression analysis using
backward selection with the variables parity, maternal
age, education level, fear level antepartum, duration of
labour and obstetric intervention/complication, the asso-
ciation between receiving pharmacological pain relief
and fear of childbirth reported postpartum remained sig-
nificant (p = 0.02). Women who used epidural analgesia,
more often reported fear of childbirth postpartum than
women who did not use pain relief (OR 3.5; CI 1.5–8.2),
while for remifentanil-PCA this difference was not sta-
tistically significant (OR 1.7; CI 0.7–4.3)(Table 3).
Discussion
Main findings
We observed that women with fear of childbirth ante-
partum more often requested pain relief, although this
association did not reach statistical significance. The re-
sults of our analyses also suggest that women who re-
ceived pharmacological pain relief more often reported
experienced fear of childbirth postpartum compared to
women who did not use pain relief. This association was
statistically significant for women who used epidural
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analgesia with continuous infusion, while it did not
reach statistical significance for women who used
remifentanil-PCA.
Interpretation
The frequency of fear of childbirth antepartum (8,5%) and
fear of childbirth reported postpartum (11,7%) in our
study was in accordance with the literature [5, 10, 17].
Comparable with previous studies, we observed that
women with fear of childbirth antepartum were more
likely to request pain relief during labour, although our
study did not show statistical significance [8, 10, 26]. This
might be because of a lack of power in our study. Another
explanation could be that our study population consisted
of low risk labouring women under the care of a primary
care midwife. It is assumed that women receive continu-
ous support of labour during midwife-led care. Previous
research showed that continuous support of labour
results in less pharmacological pain relief [27–29].
Also, one might assume that these healthy women prob-
ably have other expectations towards pain and the use of
pharmacological pain relief compared to women with a
medium to high obstetric risk already under care of an ob-
stetrician. Besides, it is known that there are different rea-
sons for fear of childbirth antepartum, like fear of the
unknown, loss of control and labour pain [5]. Geissbueh-
ler et al. found fear of labour pain as one of the most fre-
quent reasons for fear of childbirth [29]. However, we did
a
b
Fig. 1 a. Flowchart of women in the RAVEL trial who did complete the W-DEQ A (antepartum). b. Flowchart of women in the RAVEL trial who
did complete the W-DEQ B (postpartum)
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not have information about the background of fear of
childbirth in our study population.
Our study shows that women who used epidural anal-
gesia with continuous infusion more often report fear of
childbirth postpartum compared to women who did not
use pharmacological pain relief. We did not find this
relation for the use of remifentanil-PCA. Previous stud-
ies did not distinguish between the method of pain relief,
but usually only reported about epidural analgesia. To
our knowledge, there are no studies about the associ-
ation between remifentanil-PCA and fear of childbirth.
Possibly, the effect of remifentanil-PCA at the birth
Table 1 Baseline characteristics at randomisation of women who participated in the RAVEL study and who did complete the W-
DEQ antepartum and/or the W-DEQ postpartum
W-DEQ antepartum (n = 374) n (%) W-DEQ
postpartum (n = 315) n (%)
RAVEL
study n = 409 (%)
Gestational age (weeks), median [IQR] 36 [34–38] 36 [34–38] 36 [34–38]
Maternal age (years), mean (SD) 32 (4.1) 32 (4.0) 32 (4.1)
Randomisation allocation RAVEL trial
Remifentanil-PCA 186 (50) 169 (54) 203 (50)
Epidural analgesia 188 (50) 146 (46) 206 (50)
Ethnic origin
Western 342 (91) 293 (93) 372 (91)
Non Western 32 (9) 22 (7) 37 (9)
Education
≤ Low-medium professional school 75 (20) 53 (17) 81 (20)
≥ Higher professional school 288 (77) 253 (80) 314 (77)
Unknown 11 (3) 9 (3) 14 (3)
Body mass index (kg/m2) mean (SD) 23 (3.4) 23 (3.4) 23 (3.4)
Parity
0 262 (70) 222 (71) 284 (69)
≥ 1 112 (30) 93 (30) 125 (31)
Pain relief requested
No 186 (50) 157 (50) 203 (50)
Yes 188 (50) 158 (50) 206 (50)
Pain relief received
No 219 (59) 185 (59) 239 (58)
Yes 155 (41) 130 (41) 170 (42)
Remifentanil-PCA 80 (21) 72 (23) 94 (23)
Epidural analgesia 72 (19) 55 (18) 76 (19)
Other (opioid) 3 (1) 3 (1) 3 (1)
W-DEQ score (level of fear of childbirth)
< 85 (low-medium fear of childbirth) 342 (91) 278 (88) –
≥ 85 and < 100 (intense fear of childbirth) 30 (8) 26 (8) –
≥ 100 (very intense/fobic fear of childbirth) 2 (1) 11 (4) –
IQR interquartile range, SD standard deviation
Table 2 Association between antepartum fear of childbirth and request for pharmacological pain relief
Request pain relief, n = 188
n (%)
No request pain relief, n = 186
n (%)
OR (95% CI) Adjusted
OR (95% CI)
Fear of childbirth antepartuma
Low-medium fear of childbirth (< 85) [ref] 168 (89) 174 (94) 1.7 (0.8–3.6) 2.0 (0.8–4.6)
(Very) intense fear of childbirth (≥85) 20 (11) 12 (7)
aAdjusted for parity; maternal age; education level; previous first trimester loss; antepartum HADS score; previous vaginal instrumental delivery
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experience towards experienced fear of childbirth is
different from the effect of epidural analgesia- a more
invasive method of pain relief. Although epidural anal-
gesia gives lower pain scores and a better satisfaction
with pain relief, our study suggests that women who
received remifentanil-PCA do not report more fear of
childbirth postpartum compared to women who used
epidural analgesia with continuous infusion [14, 15].
Our study population contains mainly Western, highly
educated women. In addition, less women with a low
education level completed the W-DEQ postpartum com-
pared to women with a high education level. This may
have influenced of the results of our study. Fear of child-
birth reported postpartum occurred more often in
women with a low education level (23%) compared to
women with a high education level (9%). This is in
accordance with Laursen et al. who found that fear of
childbirth is expected to be higher in women with a
lower education level [18]. Therefore, our results are
probably an underestimation of fear of childbirth
reported postpartum by low-risk pregnant women which
limits the generalisability of our study.
The result that fear of childbirth antepartum is cogent
related to fear of childbirth reported postpartum is con-
sistent with previous studies [7, 17, 20, 24]. The child-
birth experience is more affected by already existing
antepartum fear of childbirth than by interventions or
complications during labour [20, 30]. It is shown before
that fear of childbirth is associated with obstetric inter-
vention/complications as well as with caesarean section
as preferred mode of delivery [5, 9]. This knowledge
makes it important to distinguish fear of childbirth ante-
partum. Once recognized, women can make an informed
choice for treatment of their fear of childbirth in order
to prevent both obstetric intervention/complications and
fear of childbirth reported postpartum as well as peri-
natal costs [30–32].
Strengths and limitations
The main strength of our study is the high response rate
for both questionnaires, antepartum (91%) and postpar-
tum (77%). Second, our study population was extracted
from the randomised RAVEL trial with many possible
confounders for fear of childbirth included in the data-
set. We had the opportunity to adjust for most potential
confounders. Another strength is that our study distin-
guishes the applied method of pain relief -instead of pain
relief in general- in relation to fear of childbirth reported
postpartum.
Our study also has weaknesses. First, the group of
women with fear of childbirth reported postpartum is
relatively small. This study was a secondary analysis
therefore it is possible that we did not find associations
because of a lack of statistical power. Second, we com-
bined obstetric interventions and complications into one
variable ‘obstetric intervention/complication’ although
the influence of every single variable at the onset of fear
of childbirth postpartum could be different. Due to our
small study population and the low rates of the interven-
tions and complications it was not possible to use the
Table 3 Association between whether or not pharmacological pain relief was received and fear of childbirth reported postpartum:
multivariable analysis
Variable Fear level reported postpartum
low-medium (< 85)
n = 278
Fear level reported postpartum (very) intense (≥85)
n = 37
Adjusted ORa (95% CI)
Pain relief
No pain relief [ref] 174 (63%) 14 (38%)
Remifentanil-PCA 63 (23%) 9 (24%) 1.7 (0.7–4.3)
Epidural analgesia 41 (15%) 14 (38%) 3.5 (1.5–8.2)
Fear of childbirth antepartum
Low-medium (< 85) 255 (92%) 29 (78%) 3.9 (1.4–10.8)
[ref]
High (≥85 and < 100) 16 (6%) 8 (22%)
& severe (≥100)
Missing 7 (3%) 0
Education level
(professional school) 0.4 (0.2–0.9)
≤Medium [ref] 41 (15%) 12 (32%)
≥ Higher 229 (82%) 24 (65%)
Missing 8 (3%) 1 (3%)
aAdjusted for maternal age; parity; education level; duration of labour; obstetric intervention/complication; fear of childbirth antepartum (W-DEQ A)
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individual variables in our analysis. Third, although we ad-
justed for the majority of potential confounding variables
residual confounding could exist. Earlier research showed
some other possible confounders which could influence
fear of childbirth reported postpartum, for instance lack of
social support, dissatisfaction with partnership and insuffi-
cient support of the caregiver [16, 21]. Information about
these aspects was not available in our dataset, therefore
we did not have the possibility to adjust for all potential
confounders.
Furthermore, a possible weakness for the extrapolation
to practice could be the population the randomised de-
sign of the RAVEL study. The fact that women knew
that they were allocated to the remifentanil-PCA group
or the epidural analgesia group might have influenced
their psychological behaviour. For example, if women
had a preference for the trial arm they were not allo-
cated to, they would probably have tried harder to
cope with labour pain without any form of labour
analgesia. Besides, remifentanil-PCA and epidural an-
algesia were given on a request for pain relief irre-
spective of the stage of labour. In contrast to daily
practice, when the stage of labour is taken into ac-
count to distinguish which method of pain relief will
be appropriate. There could have been influence from
this randomised design on the outcome measure fear
of childbirth reported postpartum, for example de-
pending of the satisfaction with pain relief the woman
has experienced. In addition, the number of women
who reported fear of childbirth postpartum could
have been influenced by women who did not receive
pain relief unless a request for it. This could have led
to an overvaluation of women with fear of childbirth
postpartum in the group of women who did not use
pain relief. Lastly, in the RAVEL study epidural anal-
gesia was given with continuous infusion which is as-
sociated with a greater need for provider-delivered
boluses for breakthrough pain compared to patient
controlled epidural analgesia. It is possible that the
quality of analgesia from continuous epidural infu-
sions negatively affected fear of childbirth postpartum
[33]. To judge on extrapolation to the comparison be-
tween epidural-PCA and remifentanil-PCA further re-
search is needed.
Conclusions
Women with fear of childbirth antepartum more fre-
quently requested pain relief, but this association did not
reach statistical significance. Women who received
pharmacological pain relief reported more frequently
fear of childbirth postpartum. When looking at fear of
childbirth postpartum, epidural analgesia with continu-
ous infusion does not seem to be preferred over
remifentanil-PCA as method of pain relief.
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